rs483352690
Variant summary
Our verdict is Pathogenic. Variant got 18 ACMG points: 18P and 0B. PM1PM2PM5PP3_StrongPP5_Very_Strong
The NM_000321.3(RB1):c.1960G>A(p.Val654Met) variant causes a missense, splice region change. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. 2/3 splice prediction tools predicting alterations to normal splicing. Variant has been reported in ClinVar as Pathogenic (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. V654L) has been classified as Likely pathogenic.
Frequency
Consequence
NM_000321.3 missense, splice_region
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 18 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
RB1 | NM_000321.3 | c.1960G>A | p.Val654Met | missense_variant, splice_region_variant | 19/27 | ENST00000267163.6 | NP_000312.2 | |
RB1 | NM_001407165.1 | c.1960G>A | p.Val654Met | missense_variant, splice_region_variant | 19/27 | NP_001394094.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
RB1 | ENST00000267163.6 | c.1960G>A | p.Val654Met | missense_variant, splice_region_variant | 19/27 | 1 | NM_000321.3 | ENSP00000267163 | P1 | |
RB1 | ENST00000650461.1 | c.1960G>A | p.Val654Met | missense_variant, splice_region_variant | 19/27 | ENSP00000497193 | ||||
RB1 | ENST00000643064.1 | c.194+74906G>A | intron_variant | ENSP00000496005 | ||||||
RB1 | ENST00000480491.1 | downstream_gene_variant | 5 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 exome Cov.: 31
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
Retinoblastoma Pathogenic:2
Pathogenic, criteria provided, single submitter | clinical testing | Genetic Diagnostic Laboratory, University of Pennsylvania School of Medicine | May 20, 2024 | Case and Pedigree Information: BILATERAL CASES:0, UNILATERAL CASES:2, TOTAL CASES:2, PEDIGREES:1. ACMG Codes Applied:PVS1, PM2 - |
Pathogenic, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Sep 16, 2021 | This variant disrupts the c.1960G nucleotide in the RB1 gene. Other variant(s) that disrupt this nucleotide have been determined to be pathogenic (PMID: 12541220, 15605413, 18181215, 21615945, 28606269). This suggests that this nucleotide is clinically significant, and that variants that disrupt this position are likely to be disease-causing. For these reasons, this variant has been classified as Pathogenic. Variants that disrupt the consensus splice site are a relatively common cause of aberrant splicing (PMID: 17576681, 9536098). Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may disrupt the consensus splice site. Algorithms developed to predict the effect of missense changes on protein structure and function are either unavailable or do not agree on the potential impact of this missense change (SIFT: "Deleterious"; PolyPhen-2: "Probably Damaging"; Align-GVGD: "Class C0"). ClinVar contains an entry for this variant (Variation ID: 100808). This missense change has been observed in individual(s) with retinoblastoma (PMID: 14722923, 15884040, 22084214, 26925970, 29568217). It has also been observed in individuals without personal history of RB1-related conditions (PMID:29568217, 22084214, 26925970, 14722923). This variant is not present in population databases (ExAC no frequency). This sequence change replaces valine with methionine at codon 654 of the RB1 protein (p.Val654Met). The valine residue is highly conserved and there is a small physicochemical difference between valine and methionine. This variant also falls at the last nucleotide of exon 19, which is part of the consensus splice site for this exon. - |
not provided Pathogenic:1Uncertain:1
Likely pathogenic, no assertion criteria provided | literature only | Richard Lifton Laboratory, Yale University School of Medicine | - | - - |
Uncertain significance, flagged submission | literature only | Richard Lifton Laboratory, Yale University School of Medicine | - | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at